Cargando…
AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editrice Gastroenterologica Italiana S.r.l.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451193/ http://dx.doi.org/10.1016/S1590-8658(21)00611-3 |
| _version_ | 1784569790896013312 |
|---|---|
| author | Marsilio, I. Maniero, D. Lorenzon, G. Rigo, A. Cardin, R. Facchin, S. Barberio, B. D’Incà, R. Zingone, F. Bahur, B. Bray, K. Savarino, E. |
| author_facet | Marsilio, I. Maniero, D. Lorenzon, G. Rigo, A. Cardin, R. Facchin, S. Barberio, B. D’Incà, R. Zingone, F. Bahur, B. Bray, K. Savarino, E. |
| author_sort | Marsilio, I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8451193 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editrice Gastroenterologica Italiana S.r.l. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84511932021-09-20 AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Marsilio, I. Maniero, D. Lorenzon, G. Rigo, A. Cardin, R. Facchin, S. Barberio, B. D’Incà, R. Zingone, F. Bahur, B. Bray, K. Savarino, E. Dig Liver Dis Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD Editrice Gastroenterologica Italiana S.r.l. 2021-09 2021-09-20 /pmc/articles/PMC8451193/ http://dx.doi.org/10.1016/S1590-8658(21)00611-3 Text en Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. All rights reserved. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD Marsilio, I. Maniero, D. Lorenzon, G. Rigo, A. Cardin, R. Facchin, S. Barberio, B. D’Incà, R. Zingone, F. Bahur, B. Bray, K. Savarino, E. AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title | AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_full | AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_fullStr | AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_full_unstemmed | AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_short | AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| title_sort | af.48 comparative assessment of adalimumab trough levels between point-of-care testing and current standard of care (enzyme linked immunosorbent assay) in patients with inflammatory bowel disease |
| topic | Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451193/ http://dx.doi.org/10.1016/S1590-8658(21)00611-3 |
| work_keys_str_mv | AT marsilioi af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT manierod af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT lorenzong af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT rigoa af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT cardinr af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT facchins af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT barberiob af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT dincar af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT zingonef af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT bahurb af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT brayk af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease AT savarinoe af48comparativeassessmentofadalimumabtroughlevelsbetweenpointofcaretestingandcurrentstandardofcareenzymelinkedimmunosorbentassayinpatientswithinflammatoryboweldisease |